These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 36992399)

  • 1. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D; Ramadan L; Kruglova N
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X; Shi W; Geng LZ; Xu JP
    Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
    Wilbie D; Walther J; Mastrobattista E
    Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
    Bloomer H; Khirallah J; Li Y; Xu Q
    Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of CRISPR-Cas12a Ribonucleoprotein Complex for Genome Editing in an Embryogenic Citrus Cell Line.
    Fang H; Culver JN; Niedz RP; Qi Y
    Methods Mol Biol; 2023; 2653():153-171. PubMed ID: 36995625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing.
    Onuma H; Sato Y; Harashima H
    J Control Release; 2023 Mar; 355():406-416. PubMed ID: 36773957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition.
    Suzuki Y; Onuma H; Sato R; Sato Y; Hashiba A; Maeki M; Tokeshi M; Kayesh MEH; Kohara M; Tsukiyama-Kohara K; Harashima H
    J Control Release; 2021 Feb; 330():61-71. PubMed ID: 33333121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
    Bykonya AG; Lavrov AV; Smirnikhina SA
    Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome editing via delivery of Cas9 ribonucleoprotein.
    DeWitt MA; Corn JE; Carroll D
    Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
    Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
    Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells.
    Tyumentseva MA; Tyumentsev AI; Akimkin VG
    PLoS One; 2021; 16(11):e0259812. PubMed ID: 34752487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
    Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing.
    Mun D; Kang JY; Kim H; Yun N; Joung B
    J Control Release; 2024 Jun; 370():798-810. PubMed ID: 38754633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
    Perera OP; Little NS; Pierce CA
    PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron-Confined CRISPR/Cas9-Ribonucleoprotein Delivery System for Redox-Responsive Gene Editing.
    Qiu L; Sun M; Chen L; Jiang J; Fu Z; Wang Y; Bi Y; Guo Q; Bai H; Chen S; Gao L; Chang G
    Small; 2024 Jul; 20(30):e2309431. PubMed ID: 38402425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms.
    Farboud B; Jarvis E; Roth TL; Shin J; Corn JE; Marson A; Meyer BJ; Patel NH; Hochstrasser ML
    J Vis Exp; 2018 May; (135):. PubMed ID: 29889198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.